Drug and Alcohol Testing Market expected to reach $6.3 Billion by 2019 – Research
The global drug and alcohol testing market is expected to reach $6.3 billion by 2019 from $4 billion in 2014, growing at a CAGR of 9.5% from 2014 to 2019. Major factors driving the growth of this market include high usage of alcohol, prescribed drugs and illicit drugs, growing aging population that leads to increased use of alcohol and prescription drug use, funding by the U.S. federal governments for drug testing, enactment of stringent laws in developed countries, and growing awareness for drug testing in developing nations. However, privacy rights in some countries may hinder the growth of this market. In such countries, drug and alcohol testing may be seen as a violation of an individual’s rights to privacy. Emerging economies such as India, China, and Brazil present an array of opportunities for this market.
The statistics are given by “Drug Screening Market Report by Sample Type, Products & Services – 2019”
Request PDF brochure of this report at – http://www.marketsandmarkets.com/pdfdownload.asp?id=162987773
The report segments the drug and alcohol testing market on the basis of products and services, sample types, end users, and regions. In the samples segment, urine samples accounted for the largest share in 2014. The breath sample segment will grow at the highest CAGR in the forecast period. Breath testing is the most common test performed for driving under influence (DUI) cases. Factors such as the rise in the number of roadside accidents due to DUI and government initiatives to curb DUI are the factors driving the growth of drug and alcohol testing market for breath testing. The oral fluid testing segment has also gained prominence in the market. This can be attributed to the noninvasive nature of this test where samples can be collected under direct observation, and thus the adulteration of said sample can be prevented. Furthermore, with oral fluid testing, the concentrations of many drugs can be closely correlated with blood concentrations.
Based on region, the market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in this market.
Key players in the drug and alcohol testing market include Quest Diagnostics (U.S.), Laboratory Corporation of America Holdings (U.S.), Alere, Inc., (U.S.), Roche Diagnostics (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Siemens Healthcare (Germany), Express Diagnostics Int’l Inc. (U.S.), Shimadzu (Japan), and MPD, Inc. (U.S.).
Inquiries before buying this report – http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=162987773
Discuss with report analyst to know more – http://www.marketsandmarkets.com/speaktoanalyst.asp?id=162987773
About Report Publisher:
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.